NO970651L - Levering av nukleinsyrer - Google Patents

Levering av nukleinsyrer

Info

Publication number
NO970651L
NO970651L NO970651A NO970651A NO970651L NO 970651 L NO970651 L NO 970651L NO 970651 A NO970651 A NO 970651A NO 970651 A NO970651 A NO 970651A NO 970651 L NO970651 L NO 970651L
Authority
NO
Norway
Prior art keywords
pct
carbon atoms
acyl group
group derived
fatty acid
Prior art date
Application number
NO970651A
Other languages
English (en)
Other versions
NO970651D0 (no
Inventor
Robert Whittaker
Fiona Helen Cameron
Veronika Bender
Minoo Mogghadham
Philip Anthony Jennings
Original Assignee
Commw Scient Ind Res Org
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commw Scient Ind Res Org filed Critical Commw Scient Ind Res Org
Publication of NO970651D0 publication Critical patent/NO970651D0/no
Publication of NO970651L publication Critical patent/NO970651L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C07K14/003—Peptide-nucleic acids (PNAs)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

En fremgangsmåte for innføring av nukleinsyrer i celler som innbefatter eksponering av cellene for en forbindelse som har formelen (I), hvor w er en nukleinsyre, x er et peptid eller en aminosyre, y er en linker som har en kjedelengde tilsvarende 1 til 20 karbonatomer eller er fraværende, Rer H eller CHO - R; og Rj, Rog Rer like eller forskjellige og er enten hydrogen metyl, etyl, hydroksyl eller en acylgruppe avledet fra en fettsyre som har en karbonkjede på 3 til 24 karbonatomer som er mettede eller umettede, forutsatt at minst en av R, Rog Rer en acylgruppe avledet fra en fettsyre, eller en forbindelse med formelen w XVNHCH2CH2OR5, hvor w er en nukleinsyre, x er et peptid eller en aminosyre, y er linker med en kjedelengde tilsvarende 1 til 20 karbonatomer eller er fraværende, Rer en acylgruppe avledet fra en fettsyre med en karbonkjede på 3 til 24 karbonatomer som er mettede eller umettede. Disse forbindelsene er også beskrevet.
NO970651A 1994-08-16 1997-02-12 Levering av nukleinsyrer NO970651L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPM7476A AUPM747694A0 (en) 1994-08-16 1994-08-16 Delivery of nucleic acids and peptides
AUPM7677A AUPM767794A0 (en) 1994-08-16 1994-08-25 Delivery of nucleic acids and peptides
PCT/AU1995/000505 WO1996005218A1 (en) 1994-08-16 1995-08-16 Delivery of nucleic acids

Publications (2)

Publication Number Publication Date
NO970651D0 NO970651D0 (no) 1997-02-12
NO970651L true NO970651L (no) 1997-04-02

Family

ID=25644738

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970651A NO970651L (no) 1994-08-16 1997-02-12 Levering av nukleinsyrer

Country Status (14)

Country Link
US (1) US5906922A (no)
EP (1) EP0777679B1 (no)
JP (1) JP3763577B2 (no)
CN (1) CN1210290C (no)
AT (1) ATE253588T1 (no)
AU (3) AUPM747694A0 (no)
CA (1) CA2197653C (no)
DE (1) DE69532081T2 (no)
DK (1) DK0777679T3 (no)
FI (1) FI970648A (no)
NO (1) NO970651L (no)
NZ (1) NZ290757A (no)
RU (1) RU2160278C2 (no)
WO (1) WO1996005218A1 (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674908A (en) 1993-12-20 1997-10-07 Life Technologies, Inc. Highly packed polycationic ammonium, sulfonium and phosphonium lipids
US6989434B1 (en) 1994-02-11 2006-01-24 Invitrogen Corporation Reagents for intracellular delivery of macromolecules
US5795587A (en) * 1995-01-23 1998-08-18 University Of Pittsburgh Stable lipid-comprising drug delivery complexes and methods for their production
US6008202A (en) * 1995-01-23 1999-12-28 University Of Pittsburgh Stable lipid-comprising drug delivery complexes and methods for their production
FR2732895B1 (fr) * 1995-04-11 1997-05-16 Pasteur Merieux Serums Vacc Utilisation d'un compose amphipathique cationique comme agent de transfection, comme adjuvant de vaccin, ou comme medicament
US20030069173A1 (en) * 1998-03-16 2003-04-10 Life Technologies, Inc. Peptide-enhanced transfections
US6051429A (en) 1995-06-07 2000-04-18 Life Technologies, Inc. Peptide-enhanced cationic lipid transfections
EP0874910A4 (en) * 1995-06-07 1999-04-21 Life Technologies Inc ENHANCED CATIONIC LIPID TRANSFECTION BY PEPTIDES
EP0775751A3 (en) * 1995-11-22 1998-06-10 F. Hoffmann-La Roche Ag Cell transfection
AUPN741696A0 (en) * 1996-01-05 1996-01-25 Commonwealth Scientific And Industrial Research Organisation Delivery of nucleic acids ii
US7135191B2 (en) * 1997-09-04 2006-11-14 Zsolt Istvan Hertelendy Urogenital or anorectal transmucosal vaccine delivery system
CA2350882C (en) 1998-11-12 2011-02-22 Invitrogen Corporation Transfection reagents
EP1285081A2 (en) * 2000-05-30 2003-02-26 ICH Productions Limited Improved methods of transfection
AUPR621501A0 (en) 2001-07-06 2001-08-02 Commonwealth Scientific And Industrial Research Organisation Delivery of ds rna
WO2003049763A1 (en) * 2001-12-12 2003-06-19 Fh Faulding & Co Limited Composition for the preservation of viruses
AUPS145602A0 (en) * 2002-03-28 2002-05-09 Commonwealth Scientific And Industrial Research Organisation Composition and method for killing tumours
WO2004028442A2 (en) * 2002-09-26 2004-04-08 Pfizer Products Inc. Use of excipients to increase dna uptake by swine muscle cells
JP2006517790A (ja) * 2003-01-09 2006-08-03 インヴィトロジェン コーポレーション ポリペプチド−核酸複合体の細胞の送達および活性化
EP1938843A1 (en) * 2006-12-19 2008-07-02 Novosom AG Lipids and lipid assemblies comrising transfection enhancer elements
US8193246B2 (en) * 2006-12-19 2012-06-05 Marina Biotech, Inc. Lipids and lipid assemblies comprising transfection enhancer elements
EP1935434A1 (en) * 2006-12-19 2008-06-25 Novosom AG Construction and use of transfection enhancer elements
WO2012118780A2 (en) * 2011-02-28 2012-09-07 Polytechnic Institute Of New York University Preparation of peptide mixtures by protease catalysis designed to provide useful biological and physical properties
US9895005B2 (en) * 2014-05-21 2018-02-20 Kids Ii, Inc. Convertible child seat
EP3169310A1 (en) 2014-07-15 2017-05-24 Life Technologies Corporation Compositions with lipid aggregates and methods for efficient delivery of molecules to cells
WO2024018762A1 (ja) * 2022-07-19 2024-01-25 国立大学法人北海道大学 ｐＨ感受性カチオン性脂質及び脂質ナノ粒子

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286634A (en) * 1989-09-28 1994-02-15 Stadler Joan K Synergistic method for host cell transformation
DE69024230T2 (de) * 1989-12-22 1996-05-02 Commw Scient Ind Res Org An fette gebundene aminosäuren, peptide oder deren derivate
US5279833A (en) * 1990-04-04 1994-01-18 Yale University Liposomal transfection of nucleic acids into animal cells
US5264618A (en) * 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
JP2958076B2 (ja) * 1990-08-27 1999-10-06 株式会社ビタミン研究所 遺伝子導入用多重膜リポソーム及び遺伝子捕捉多重膜リポソーム製剤並びにその製法
WO1993002706A1 (en) * 1991-07-26 1993-02-18 Commonwealth Scientific And Industrial Research Organisation Self-adjuvanting peptide vaccine delivery system and production thereof
CA2122030C (en) * 1991-10-24 1997-03-04 Muthiah Manoharan Derivatized oligonucleotides having improved uptake and other properties
US5858784A (en) * 1991-12-17 1999-01-12 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol- and liposome-based delivery
EP0632722A4 (en) * 1992-03-20 1997-07-30 Baylor College Medicine DNA TRANSPORTATION SYSTEM AND INSTRUCTIONS FOR USE.
US5329029A (en) * 1992-11-05 1994-07-12 Wan Barbara Y Phosphatidylalkanolamine derivatives and their use in generating phospholipid conjugates
NZ265818A (en) * 1993-04-19 1997-09-22 Medisorb Technologies Internat Compositions of nucleic acids encapsulated with molecules that facilitate uptake and integration into living cells
US5792786A (en) * 1993-08-02 1998-08-11 Commonwealth Scientific And Industrial Research Organisation Non-steroidal anti-inflammatory fatty acid conjugates and their therapeutic use thereof

Also Published As

Publication number Publication date
AU3158595A (en) 1996-03-07
NZ290757A (en) 2000-09-29
JPH10509862A (ja) 1998-09-29
AU684383B2 (en) 1997-12-11
DE69532081D1 (de) 2003-12-11
EP0777679B1 (en) 2003-11-05
FI970648A (fi) 1997-04-07
CA2197653C (en) 2009-04-28
CA2197653A1 (en) 1996-02-22
CN1158619A (zh) 1997-09-03
AUPM767794A0 (en) 1994-09-15
ATE253588T1 (de) 2003-11-15
EP0777679A1 (en) 1997-06-11
WO1996005218A1 (en) 1996-02-22
FI970648A0 (fi) 1997-02-14
DE69532081T2 (de) 2004-09-09
CN1210290C (zh) 2005-07-13
JP3763577B2 (ja) 2006-04-05
EP0777679A4 (en) 1997-10-08
NO970651D0 (no) 1997-02-12
RU2160278C2 (ru) 2000-12-10
AUPM747694A0 (en) 1994-09-08
DK0777679T3 (da) 2003-12-01
US5906922A (en) 1999-05-25

Similar Documents

Publication Publication Date Title
NO970651D0 (no) Levering av nukleinsyrer
DE69711391D1 (de) Verbessertes verfahren zum herstellen von geschützten 3,4-dihydroxybuttersäure estern
SE8403931L (sv) Treo-3-amino-2-hydroxi-4-oxosmorsyraderivat
ES2073706T3 (es) Nuevos derivados de acidos fosfono-alcanopolicarboxilicos y sus utilizaciones.
DE59603910D1 (de) Hitzeschild mit befestigung für auspuffanlagen
AU534233B2 (en) Muramyldipeptide derivatives
DE59405810D1 (de) Verfahren zur herstellung von festen esterquats
KR840005733A (ko) 무라밀 펩타이드의 제조방법
NZ502837A (en) Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the DNA polymerase of hepatitis B virus (HBV)
NO20023276L (no) Fremgangsmåter fremstilling av betulinsyre
ATE221516T1 (de) Wollwachs
BG103319A (en) Method for the preparation of hydroxamic acids
ATE274912T1 (de) Etherderivate von pseudopterosin
DE69507139T2 (de) Verfahren zur herstellung von 4-amino-delta 4-3-ketosteroiden via 4-nitro-delta-4-3-ketosteroiden
ATE184590T1 (de) Verfahren zur herstellung von fettsäureamiden und ihre verwendung
GEP19970937B (en) Method of producing derivatives of muramyldipeptide
UA23979A (uk) СПОСІБ ОДЕРЖАHHЯ 13АlРhА-3-ГІДРОКСИ-17-КЕТОСТЕРОЇДІВ АHДРОСТАHОВОГО РЯДУ
FR2791666B1 (fr) Diol fluore et son procede de preparation
TW347381B (en) Method of controlling the deposition of scale imparting precipitates
HUP9903004A3 (en) Process for preparing 3-pyrroline-2-carboxylic acid derivatives

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application